Lead researcher
Dr Andreas Behren, Dr Katherine Woods, Prof Jonathan Cebon
Institution
Cancer Immunobiology, Olivia Newton-John Cancer Research Institute
Years funded
2015
Melanoma is responsible for the majority of skin
cancer related deaths and its incidence is rising. Strategies to harness the
body's own immune system have shown promising anti-tumour effects, however,
only a group of patients shows a response. We identified a novel molecule in
melanoma that may block the immune system from efficiently destroying the
tumour. This application aims to understand and interfere with the
immune-suppressive action of this protein to create new therapeutic options.
Lay Report:
A novel antibody target in melanoma
Funding Body
Cancer Council Research Grant
Funding
93089